Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study evaluated a mobile health intervention delivered by clinical pharmacists and health coaches to improve blood glucose levels in adults with type 2 diabetes, showing a significant reduction in Hemoglobin A1c.
This study evaluated the effectiveness of an online low glycemic index diet for managing type 2 diabetes, showing significant improvements in several health markers.
This study evaluated the impact of peer-created digital storytelling videos on psychological outcomes in individuals with Type 1 diabetes. Significant improvements in diabetes distress, burnout, and depressive symptoms were observed in the intervention group.
This study compared diabetes self-management education via telemedicine to face-to-face encounters, finding significant improvements in glycemic control and diabetes knowledge.
The TELEGLAM study evaluated a telemedicine system for patients with gestational diabetes mellitus, finding significant cost reductions and improved quality of life scores compared to standard care.
The study evaluated a three-tiered linkage management model for T2DM, finding significant improvements in glycemic control and self-management.
The study evaluated the effectiveness of the PREDIABETEXT digital health intervention for managing prediabetes. It found a nonsignificant reduction in HbA1c levels.
This study compared Family-DSMES and Standard-DSMES in participants with diabetes, finding significant improvements in diabetes-related family involvement with Family-DSMES.
A value-based hospital-community-family linkage program improved blood glucose management in elderly patients with type 2 diabetes compared to conventional management.
This study evaluated the app-based intervention Mebix for individuals with Type 2 diabetes, finding significant improvements in HbA1c levels, weight loss, and diabetes-related distress compared to a placebo app.
